FMC/$FMC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About FMC
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
- Ticker
- $FMC
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 5,500
- Headquarters
- Philadelphia, United States
- Website
- www.fmc.com
FMC Metrics
BasicAdvanced
$964M
-
-$33.36
0.46
$0.32
5.16%
Price and volume
Market cap
$964M
Beta
0.46
52-week high
$18.29
52-week low
$4.37
Average daily volume
7.5M
Dividend rate
$0.32
Financial strength
Current ratio
1.659
Quick ratio
0.891
Long term debt to equity
416.305
Total debt to equity
439.758
Interest coverage (TTM)
-1.57%
Profitability
EBITDA (TTM)
-263
Gross margin (TTM)
18.03%
Net profit margin (TTM)
-151.18%
Operating margin (TTM)
-15.28%
Effective tax rate (TTM)
-38.31%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
-2.69%
Return on equity (TTM)
-218.93%
Valuation
Price to revenue (TTM)
0.281
Price to book
86.8
Price to tangible book (TTM)
-0.42
Price to free cash flow (TTM)
2.677
Free cash flow yield (TTM)
37.35%
Free cash flow per share (TTM)
2.316
Dividend yield (TTM)
5.16%
Forward dividend yield
5.16%
Growth
Revenue change (TTM)
-21.99%
Earnings per share change (TTM)
684.70%
3-year revenue growth (CAGR)
-17.22%
10-year revenue growth (CAGR)
0.23%
3-year earnings per share growth (CAGR)
104.01%
10-year earnings per share growth (CAGR)
82.00%
3-year dividend per share growth (CAGR)
-67.45%
10-year dividend per share growth (CAGR)
-19.02%
What the Analysts think about FMC
Analyst ratings (Buy, Hold, Sell) for FMC stock.
Analyst projections of the future price of FMC stock.
Bulls say / Bears say
The costly channel reset may remove a key obstacle to sales: FMC is simplifying its US pricing and rebate model and discounting selected channel stock, with management expecting this to support better performance in 2027. Its fourth-quarter outlook still points to volume growth from Brazil direct sales and new products. (FMC Corp)
Recent financing and asset-sale steps give FMC more scope to reduce debt: Tessenderlo’s $400 million equity investment closed in September, and a $200 million Corteva licensing payment has been received. FMC also plans to use the proceeds from its India business sale, agreed at $252 million, for debt reduction. (FMC Corp, FMC Corp)
FMC’s newer products offer a route to offset pressure on its older portfolio: the company reported mid-single-digit growth in its growth portfolio in the second quarter, and it has filed for Brazilian approval of rimisoxafen, a new herbicide aimed at resistant weeds. The filing is an early step, not an approval to sell. (FMC Corp, FMC Corp)
Demand and earnings have weakened sharply: third-quarter revenue excluding India and the one-off commercial actions fell 22%, with volume down 21%. FMC now expects full-year revenue to fall 28% at the midpoint and adjusted EBITDA to be negative. (FMC Corp)
Debt remains a major risk despite planned paydown: S&P put FMC’s ratings on negative CreditWatch and reported adjusted debt of about $4.2 billion, or 7.2 times adjusted EBITDA. It also warned FMC may need to amend its credit terms to maintain covenant compliance. (S&P Global Ratings)
Generic competition is pressuring FMC’s pricing power: falling market prices widened the gap between some products in the channel and current market levels, prompting price adjustments and a new US pricing model. The selected stock discounts are expected to reduce future cash collections, while the broader reset leaves execution risk. (FMC Corp, S&P Global Ratings)
Data summarised monthly by Lightyear AI. Last updated on 30 Oct 2026.
FMC Financial Performance
Revenues and expenses
FMC Earnings Performance
Company profitability
Upcoming events
No upcoming events
FMC News
AllArticlesVideos
Funds containing FMC
AllUSDEURGBP
Fund name | Fund size | $FMC weighting |
|---|---|---|
iShares Agribusiness$ISAG | $494M | 0.22% |
iShares Agribusiness£SPAG | $494M | 0.22% |
iShares Agribusiness€ISAE | $491M | 0.22% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.05% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.